S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
NASDAQ:RWLK

ReWalk Robotics (RWLK) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.64
$1.25
52-Week Range
N/A
Volume
303,600 shs
Average Volume
541,468 shs
Market Capitalization
$63.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

ReWalk Robotics MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
∞ Upside
$3.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.38) to ($0.37) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.62 out of 5 stars

RWLK stock logo

About ReWalk Robotics Stock (NASDAQ:RWLK)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

RWLK Stock News Headlines

ReWalk Robotics Ltd. (LFWD)
VA STAND Act introduced in the United States Senate
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
Lifeward Announces Reverse Share Split
Biden to Launch “FedNOW” [Move Your Money Now]
Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...
Rewalk Robotics Ltd (LFWD)
Rewalk Robotics Ltd (RWLK)
ReWalk Robotics Ltd.
ReWalk Robotics Expands Direct Sales Coverage to Canada
Preview: ReWalk Robotics's Earnings
See More Headlines
Receive RWLK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ReWalk Robotics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/11/2021
Today
4/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
NASDAQ:RWLK
Fax
N/A
Employees
56
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.00
High Stock Price Target
$3.00
Low Stock Price Target
$3.00
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-19,570,000.00
Net Margins
-238.35%
Pretax Margin
-233.51%

Debt

Sales & Book Value

Annual Sales
$5.51 million
Book Value
$1.10 per share

Miscellaneous

Free Float
58,764,000
Market Cap
$63.04 million
Optionable
Optionable
Beta
2.30
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Lawrence J. Jasinski BSMr. Lawrence J. Jasinski BS (Age 67)
    MBA, CEO & Director
    Comp: $654.03k
  • Mr. Michael A. Lawless (Age 56)
    Chief Financial Officer
    Comp: $110.24k
  • Ms. Miri Pariente (Age 47)
    Vice President of Operations, Regulatory & Quality
    Comp: $335.1k
  • Ms. Jeannine Lynch (Age 59)
    Vice President of Market Access & Strategy
    Comp: $425.98k
  • Ms. Kathleen O'Donnell
    Vice President of Marketing & New Business Development
  • Mr. Charles Remsberg
    Chief Sales Officer
  • Ms. Judy Kula
    Vice President of Customer Service, Human Resources & Business Affairs

RWLK Stock Analysis - Frequently Asked Questions

Should I buy or sell ReWalk Robotics stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ReWalk Robotics in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" RWLK shares.
View RWLK analyst ratings
or view top-rated stocks.

What is ReWalk Robotics' stock price target for 2024?

1 Wall Street analysts have issued twelve-month price objectives for ReWalk Robotics' stock. Their RWLK share price targets range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next year.
View analysts price targets for RWLK
or view top-rated stocks among Wall Street analysts.

How were ReWalk Robotics' earnings last quarter?

ReWalk Robotics Ltd. (NASDAQ:RWLK) announced its quarterly earnings results on Thursday, November, 11th. The medical device company reported ($0.06) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.06). The medical device company had revenue of $1.97 million for the quarter, compared to analyst estimates of $1.60 million. ReWalk Robotics had a negative net margin of 238.35% and a negative trailing twelve-month return on equity of 29.00%. During the same period in the prior year, the firm earned ($0.18) EPS.

What other stocks do shareholders of ReWalk Robotics own?
This page (NASDAQ:RWLK) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners